Tegoprazan-containing Sequential for H. Pylori

NCT06382493 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Tegoprazan-containing sequential H. pylori eradication therapy
DRUG: Esomeprazole-containing sequential H. pylori eradication therapy

Sponsor

Seoul National University Bundang Hospital